IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tetraphase Pharmaceuticals Inc

CUSIP: 88164N105 | 1 institutional holders

Quarters

Q2 2014Q1 2014Q4 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2014

Novo Holdings A/S900,000
0.0% of portfolio›$12.1K
StyleTurnoverLocationFiled
Novo Holdings A/S
900,000$12.1K0.0%CoreMediumHellerup, Greece2014-11-14